Leonard V. Favreau
University of Connecticut Health Center
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Leonard V. Favreau.
Drug Metabolism Reviews | 1989
John B. Schenkman; Kenneth E. Thummel; Leonard V. Favreau
Cytochrome P-450 is a large family of related enzymes comprising a number of sub-families. The different cytochrome P-450 enzymes are present in just about every phylum examined for them. They are found in prokaryotes [1], unicellular eukaryotes [2], plants [3], fowl [4], insects [5], fish [6], invertebrates [7], and mammals [8]. While the prokaryotic enzyme, e.g., P-450CAM, is a soluble hemoprotein, that of higher organisms is membrane- bound. In mammals it is located in the mitochondrial inner membrane as well as in the endoplasmic reticulum membranes. In the mammal, different forms of cytochrome P-450 are involved in such diverse reactions as steroid hormone synthesis, at several steps, and the processing of compounds of exogenous origin as well as of endogenous origin for excretion from the body. The enzymes involved in the elimination of compounds are located in the endoplasmic reticulum of most organs and tissues in the body. The very large number of such forms found suggests roles for these other than just broad, overlapping spectra of chemical detoxication.
Diabetes | 1988
Leonard V. Favreau; John B. Schenkman
Monospecific polyclonal antibodies to five constitutive hepatic microsomal cytochromes P-450 were prepared. These antibodies were used to monitor alterations in the content of the enzymes in livers of diabetic male rats. Within 3 wk of onset of streptozocin-induced diabetes, immunodetectable levels of RLM3 and RLM5 were decreased by 85 and >95%, respectively. Insulin treatment for 1 wk reversed the decline in these isozymes and restored RLM3 to 60% and RLM5 to 53% of levels found in the untreated rat. After a 2nd wk of therapy, these levels were returned to 86 and 92%, respectively. In contrast, the levels of RLM5b and RLM6 were elevated in diabetes 1.7- and 8-fold, respectively. Insulin treatment for 1 wk only slightly decreased the levels of RLM5b but completely reduced RLM6 levels to those seen in age-matched untreated rats. After the 2nd wk of insulin treatment, the level of RLM5b was almost completely restored to normal, with no additional change in the RLM6 level. The level of a fifth enzyme, RLM5a, was not markedly altered by diabetes or by insulin treatment. The results suggest there are at least three types of responses by constituents of the cytochrome P-450 population to diabetes: no change in the microsomal content, a rapid increase when insulin level declines and restoration when insulin is supplied, and a rapid decline when insulin level declines and a restoration by insulin treatment.
Archives of Biochemistry and Biophysics | 1988
Kenneth E. Thummel; Leonard V. Favreau; John E. Mole; John B. Schenkman
We have extended the characterization of RLM2, a constitutive form of rat liver cytochrome P-450, using immunochemical means to quantitate its presence in microsomes, to follow its development in maturing male and female rats, and to determine its response to prototypical P-450 inducers. In addition, RLM2 is compared to RLM2b, a form of P-450 with similar migration on SDS-PAGE and NH2-terminal amino acid sequence. RLM2b is expressed in both sexes at a level of 0.08 nmol/mg microsomal protein at 2 weeks of age. In female rats, this level is unchanged with maturation. However, in the male, the level declined with maturation to reach 0.02 nmol/mg protein by 12 weeks of age. RLM2 is a male-specific form of cytochrome P-450. Originally absent in the 2-week-old rat, it reached a level of 0.03 nmol/mg protein in the adult male, its appearance and increase coinciding with the onset of puberty. Both phenobarbital and 3-methylcholanthrene induced microsomal levels of RLM2b in the adult male and female rat. RLM2, however, was suppressed in the male rat, 58 and 42%, respectively, by the same treatments. RLM2b and RLM2 each catalyze a unique spectrum of hydroxytestosterone metabolites. RLM2b is highly site specific. In contrast, RLM2 produces several isomeric products in the same region of the testosterone molecule. Substitution of the acetyl group of progesterone for the 17-hydroxy group of testosterone did not alter the site specificity of RLM2b, but did alter it for RLM2, indicating, further, a difference in the active site conformation of the two enzymes. Although RLM2b and RLM2 responded differently to inducers and to a changing physiology during maturation, and were functionally quite distinct, the proteins showed a high degree of immunologic relatedness which is suggestive of significant structural similarities. Structural differences do exist, however, as alpha-chymotryptic digestion formed a number of peptide fragments that differed between the two proteins.
Biochemical and Biophysical Research Communications | 1987
Leonard V. Favreau; John B. Schenkman
Cytochrome P-450 dependent hydroxylation of testosterone has been measured in hepatic microsomes of control, diabetic and insulin-treated diabetic rats. The observed decrease in testosterone 16 alpha-hydroxylase activity in diabetes, an activity previously shown to be largely due to RLM5, was accompanied by a dramatic decrease in immunodetectable RLM5. Diabetic rats which received insulin had elevated testosterone 16 alpha-hydroxylase activity relative to the diabetic animals, which was accompanied by a corresponding increase in the levels of RLM5. These results provide evidence that specific constitutive cytochrome P-450 enzymes are altered in the diabetic state and that these changes are not permanent since they can be overcome, at least partially, by insulin replacement therapy.
Archives of Biochemistry and Biophysics | 1988
David Kupfer; Ingela Jansson; Leonard V. Favreau; Anthony D. Theoharides; John B. Schenkman
Previous studies demonstrated that liver microsomes from untreated rats catalyze the omega, omega-1, and omega-2 hydroxylation of prostaglandins [K. A. Holm, R. J. Engell, and D. Kupfer (1985) Arch. Biochem. Biophys. 237, 477-489]. The current study examined the regioselectivity of hydroxylation of PGE1 and PGE2 by purified forms of P-450 from untreated male and female rat liver microsomes. PGE1 was incubated with a reconstituted system containing cytochrome P-450 RLM 2, 3, 5, 5a, 5b, 6, or f4, NADPH-P-450 reductase, and dilauroylphosphatidylcholine in the presence or absence of cytochrome b5. Among the P-450 forms examined, only RLM 5 (male specific), 5a (present in both sexes), and f4 (female specific) yielded high levels of PGE hydroxylation. With PGE1, RLM 5 catalyzed solely the omega-1 hydroxylation and 5a catalyzed primarily the omega-1 and little omega and omega-2 hydroxylation. By contrast, f4 effectively hydroxylated PGE1 and PGE2 at the omega-1 and at a novel site. Based on retention on HPLC and on limited mass fragmentation, we speculate that this site is omega-3 (i.e., 17-hydroxylation). Kinetic analysis of PGE1 hydroxylation demonstrated that the affinity of f4 for PGE1 is approximately 100-fold higher than that of RLM 5; the Km values for f4, monitoring 19- and 17-hydroxylation of PGE1, were about 10 microM. Surprisingly, cytochrome b5 stimulated the activity of RLM 5a and f4, but not that of RLM 5. Hydroxylation of PGE2 by RLM 5 was at the omega, omega-1, and omega-2 sites, demonstrating a lesser regioselectivity than with PGE1. These findings show that the constitutive P-450s differ dramatically in their ability to hydroxylate PGs, in their regioselectivity of hydroxylation, and in their cytochrome b5 requirement.
Biochemical and Biophysical Research Communications | 1986
Paul P. Tamburini; Ingela Jansson; Leonard V. Favreau; Wayne L. Backes; John B. Schenkman
The interaction between NADPH-cytochrome P-450 reductase and a series of cytochrome P-450 isozymes was investigated using UV-visible spectrophotometry. In the absence of substrate the interactions between the reductase and RLM3, RLM5, and RLM5a were tight, exhibiting sub-micromolar dissociation constants and resulted in type I spectra of varying magnitude from which the following increases in the proportion of high spin hemoprotein were calculated; RLM3 (7%), RLM5 (36%), RLM5a (6%), LM2 (29%), RLM2 (0%). Preincubation of LM2 with its type I substrate benzphetamine increased the affinity of the cytochrome for the reductase. Using initial estimates of the P-450 spin states in the absence of reductase in conjunction with the spectral binding data and equations relating these parameters to the microequilibria for the association of reductase with high or low spin P-450, RLM3, RLM5, RLM5a and LM2 were shown to bind significantly more tightly to high spin P-450. The relevance of this data to the understanding of spin state influence on P-450 reduction is discussed.
Biochemical Pharmacology | 1988
Leonard V. Favreau; John B. Schenkman
The hepatic content of two individual cytochrome P-450 enzymes was analyzed in spontaneously diabetic (BB/Wor) male rats. The major male-specific form, RLM5, was found to be slightly decreased in livers of male rats shortly after the onset of diabetes. In contrast, the level of RLM6 was elevated in livers of diabetic rats that had not received insulin and had become ketotic. These results confirm that the changes in some individual forms of cytochrome P-450 after chemical (streptozotocin) induction of diabetes are also seen in the spontaneously diabetic animal. The earlier observed alterations in cytochrome P-450 are therefore due to the state of diabetes and not to inductive or depressive effects of streptozotocin.
Archives of Biochemistry and Biophysics | 1987
Lynda Cook; Daniele Ghesquier; Mahmoud N. Nagi; Leonard V. Favreau; Dominick L. Cinti
In the present study, the hepatic microsomal and peroxisomal bifunctional trans-2-enoyl CoA hydratases were isolated and purified from rats treated with 2% di-(2-ethylhexyl)phthalate for 8 days. These two enzymes (microsomal and peroxisomal) were purified with the identical purification procedures and had identical molecular masses of 76 kDa. A single band was observed on an electrophoretic gel of an equimixture of the two proteins. Both preparations had identical pIs of 8.6 and pH optima of 6.0 for the dehydrogenase (reductase) and 7.5 for the hydratase activity. Two-dimensional gel analysis of an equimixture of the two preparations showed only one band. Ouchterlony double-diffusion analysis showed that an antibody raised against the purified microsomal enzyme interacted at a point with the peroxisomal enzyme, indicating immunologic identity. Western blot analysis demonstrated that the antibody formed a single band with total microsomal and peroxisomal fractions. The antibody inhibited the enzymatic activities of both preparations in a similar manner. Interestingly, the antibody had a markedly greater inhibitory effect on the reductase activity of the two enzyme preparations, and a much less inhibitory effect on the hydratase activity, suggesting that the antigenic determinants reside at or near the catalytic site of the reductase portion of the protein. These results suggest that the microsomal and peroxisomal bifunctional proteins are identical.
Advances in Experimental Medicine and Biology | 1986
John B. Schenkman; Leonard V. Favreau; Ingela Jansson
Knowledge of the cytochrome P-450 monooxygenase system has come a long way since the reports of’its hemoprotein nature.1,2Initial studies revealed some drug and chemical-treated animals respond to challenge by such agents with an increase in the hepatic microsomal content of cytochrome P-450. It wasn’t long, however, before it was realized that the cytochrome P-450 increase was the result of an induction of different forms of cytochrome P-450.3,4
Archives of Toxicology | 1987
John B. Schenkman; Leonard V. Favreau; John E. Mole; Donald L. Kreutzer; Ingela Jansson
The cytochrome P-450 fraction of microsomes separated on lauric acid AH-Sepharose 4B columns contains about 75% of the microsomal P-450. This was finger-printed by means of two dimensional isoelectric focusing/ SDS-PAGE. Separation of the fraction by highly reproducible, standard procedures on carboxymethyl Sepharose CL6B into four fractions allowed ready isolation and purification of seven forms of P-450, RLM2, 2b, 3, f4, 5, 5a and f5a. Comparison of the four fractions CMI, CMII, CMIII and CMIV revealed qualitative differences in the proteins contained in CMI and CMII of male and female rats. Identification of these proteins revealed RLM2, present in the CMI fraction of adult male rats, is not present in detectable levels in the comparable fraction from females. Similarly, RLM3 and 5 were present in the CMII fraction of male rats but could not be detected in the corresponding fraction of females. Instead, another protein, fRLM4, was found in the females. RLM5a, found in the CMII fraction of males, was also present in females. Examination of the physical properties of these P-450 proteins revealed those isolated in the CMI and CMII fractions to have fairly neutral isoelectric points (7.1–7.6). Based upon the NH2-terminal amino acid sequence, three classes of constitutive forms of P-450 can be recognized. All of the constitutive forms have methionine in position one and leucine in position seven. By comparing sequence homologies, RLM2 and 2b form one sub-class, RLM3, f4 and 5 form a second sub-class, and P-450f and RLM5a form a third sub-class.